Islandsbanki hf.
Íslandsbanki hf. has today concluded an offering of covered bonds.
Total demand amounted to ISK 2,560m.
The non-index linked issue ISLA CB 27 was sold for an amount of ISK 620m at a yield of 2.91%. Total offers received amounted to ISK 2,560m ranging from 2.89% - 3.00%. The Bank is selling previously issued own bonds. The total nominal amount issued in the series is ISK 43,840m.
Settlement date is 29 March 2021.
For further information: Investor Relations - ir@islandsbanki.is.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sampo plc16.10.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 15 October 2025
Bavarian Nordic A/S16.10.2025 07:27:55 CEST | Press release
The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
Bavarian Nordic A/S16.10.2025 07:27:55 CEST | Pressemeddelelse
Bestyrelsen fastholder anbefaling i supplerende redegørelse vedrørende forbedret overtagelsestilbud til aktionærerne i Bavarian Nordic fra konsortium ledet af Nordic Capital og Permira
Novartis Pharma AG16.10.2025 07:15:00 CEST | Press release
Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)
F. Hoffmann-La Roche Ltd16.10.2025 07:00:00 CEST | Press release
Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD™, at the ASHG conference 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom